John Shillingford, Clinical Operations Director, Orsus Medical, describes the inherent challenges facing small-...
Malvern Panalytical’s Zetasizer Ultra to Speed-Up and Simplify Workflow
Dolomite Microfluidics, based in Royston, UK, is a brand of Blacktrace Holdings Ltd, a company which develops and manufactures groundbreaking technologies for applications in biology, chemistry, microfluidics and nanomaterials.
Manufacturers Choose the Mastersizer 3000 for Accuracy and Efficiency
In 2016, Metals and Additives LLC, a leading manufacturer and supplier of powder additives for the battery and plastics industries, purchased the Mastersizer 3000 from Malvern Panalytical.
AtreMorine for Parkinson’s Disease and Dopamine-Related Disorders
AtreMorine is a novel biopharmaceutical compound obtained through non-denaturing biotechnological procedures from the structural components of the Vicia faba L plant, for the prevention and treatment of Parkinson´s disease (PD) and related disorders.
Supporting the Pharmaceutical Industry, 21 CFR Part 11 Compliance Readiness
The purpose of this document is to describe how PANalytical systems support system owners meeting the requirements of the 21 CFR Part 11 regulations issued by the United States’ FDA.
3DforScience to Exhibit at the Partnering Convention, 11-13 November
BIO Europe Partnering is a premier bioscience conference, which brings nearly 5,000 delegates from a broad range of companies in the industry, providing the occasion for attendees to engage in structured one-on-one bio-partnering convention, reaching over 25,000 meetings held annually.
Two Powerful New Stirrers by IKA
A fresh generation of hi-tech stirrers is awaiting users in the laboratory, including the RCT 5 digital, one of the most powerful magnetic stirrers on the market and the NANOSTAR 7.5 digital overhead, an equally high performer and at the same time, highly compact.
Visuals for Bio&Health
3DforScience is a Scientific video production & 3D medical animation company for Bio&Health sector, helping pharmaceutical, biotechnology, medical device and healthcare companies for marketing campaigns.
August’s top news stories
Biopharmaceutical firm Retrophin reported that the Phase III clinical trial of fosmetpantotenate failed to meet endpoints in pantothenate kinase-associated neurodegeneration (PKAN) patients; and MyoKardia has commenced dosing of patients in a Phase I trial of small molecule MYK-224 for the treatment of hypertrophic cardiomyopathy (HCM). Clinicaltrialsarena.com wraps up the key headlines from August 2019.